Sandoz Slashes Glatiramer Price In US

Glatopa Brand Around A Quarter Of Copaxone List Price

Sandoz has cut its US wholesale price for its Glatopa glatiramer acetate brand by more than 70% to offer a substantial difference to both Teva’s Copaxone reference brand and Mylan’s generic.

Price cut
Sandoz has slashed the list price of its glatiramer acetate generic in the US by more than 70% • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation